HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$2.72
Day range
$2.68 - $2.82
Year range
$1.56 - $4.27
Market cap
173.13M USD
Avg Volume
142.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.07M | -1.09% |
Net income | -11.22M | -7.59% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.06M | 32.89% |
Total assets | 28.97M | 30.72% |
Total liabilities | 121.45M | 66.29% |
Total equity | -92.48M | — |
Shares outstanding | 62.76M | — |
Price to book | -1.79 | — |
Return on assets | -80.05% | — |
Return on capital | -193.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.22M | -7.59% |
Cash from operations | -8.54M | -11.80% |
Cash from investing | — | — |
Cash from financing | 10.00M | -0.33% |
Net change in cash | 1.46M | -38.98% |
Free cash flow | -5.86M | -21.12% |
About
Founded
2000
Headquarters
Website
Employees
14
